RecruitingPhase 1NCT03911388
Oncology
Oligodendroglioma
23
studies recruiting now
as of 7 Sept 2026
419
studies registered in total
as of 7 Sept 2026
8
countries with a recruiting site
as of 7 Sept 2026
16 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT06161974
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 3NCT05303519
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 2NCT07286292
Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
RecruitingPhase 2NCT04623931
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 23 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Oligodendroglioma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Oligodendroglioma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (IDH2, POT1).
Treatments being studied
2 approved treatments and 8 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Vorasidenib (Voranigo)Approved: Procarbazine Hydrochloride (Matulane)
Phase 3Temozolomide (Temodal)
Phase 2Abemaciclib (Verzenio)
Phase 2Antineoplaston A10
Phase 2Lb-100
Phase 2Bevacizumab (Abevmy)
Phase 2Palbociclib (Ibrance)
Phase 2Tislelizumab (Tevimbra)
Phase 1/2Disufenton Sodium
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).